IRCT20131119015455N3 IRCT 2019-12-25 Esfahan University of Medical Sciences Effect of Topical Sucralfate in Peristomal Wound Reaction prevention in Children Evaluation of the Effect of 4% Topical Sucralfate in Peristomal Wound Reaction prevention in Children with Endoscopic Percutaneous Gastrostomy in comparison with control group 2019-09-29 anticipated 44 Complete https://irct.ir/trial/43875 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Eligible individuals were randomly assigned to each of the case and control groups in a randomized block design with volume 4, Blinding description: The researcher does not know which patients receive topical sucralfate and which patients do not. 3 Peristomal Wound Reaction due to Endoscopic Percutaneous Gastrostomy. Intervention 1: Intervention group: Sucralfate gel 4% (that it will be made in School of Pharmacy and Pharmaceutical Sciences of Isfahan University of Medical Sciences) will be used immediately after gastrostomy and then 4 times daily (every 6 hours) as a thin-layer overlay covering at least one gram of skin around the ostomy site for 2 months. Intervention 2: Control group: In the control group no drug is used and rinsing with normal saline will be done. Yes - There is a plan to make this available What will be shared: Primary outcome data can be shared. When: Starting 6 months after publication To whom: People working in academic institutions Conditions: Descriptive analysis is allowed to report on data if available Where to obtain: Bahareh Abtahi Skin Diseases and Leishmaniasis Research Center, Isfahan, Iran Email: bahareh.abtahi@med.mui.ac.ir How to obtain: The request is discussed in the Center Committee and after approval, the data is submitted to the applicant over a period of approximately one month. Comments: